William Blair Issues Pessimistic Forecast for LENZ Earnings
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – William Blair decreased their Q1 2025 earnings per share (EPS) estimates for shares of LENZ Therapeutics in a report released on Thursday, March 20th. William Blair analyst L. Hanbury-Brown now anticipates that the company will post earnings per share of ($0.56) for the quarter, down from their […]
LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – William Blair decreased their Q1 2025 earnings per share (EPS) estimates for shares of LENZ Therapeutics in a report released on Thursday, March 20th. William Blair analyst L. Hanbury-Brown now anticipates that the company will post earnings per share of ($0.56) for the quarter, down from their […]
